The literature reports that NOB showed benefits for dyslipidemia in both C57BL/6 and LDL receptor-deficient (Ldlr-/-) mice fed a high-fat diet (HFD) [4,5]. The gene discussed is LDLR; the disease is metabolic syndrome.